NantHealth (NHIQ) Stock Price, News & Analysis

Company Overview

NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States, Canada, and the United Kingdom. It offers Eviti, a software-as-a-service (SaaS) based clinical decision support solution that centralizes clinical content and treatment cost data from Medicare reimbursements and treatment toxicity data; Eviti Connect, which utilizes the platform to offer pre-authorization automation that helps payers and providers navigate the complexities of cancer care; and Eviti Advisor product that allows physicians to access the Eviti platform's comprehensive library of evidence-based treatment standards and protocols to inform treatment decisions. The company also provides NaviNet, a suite of SaaS-based solution enabling payers and providers to streamline communication and consolidate information; NaviNet Open, a payer-provider collaboration platform for communication between health plans and providers; NaviNet AllPayer that provides eligibility, benefit, and claim status information to provider offices for commercial and government plans, and centers for medicare and medicaid services for Medicare beneficiaries through the NaviNet portal; and OpenNMS is an open-source network monitoring solution for enterprise-grade networks. In addition, it offers Quadris, a data solution that includes multi-data analysis, reporting, and professional services. The company was formerly known as Nant Health, LLC and changed its name to NantHealth, Inc. in June 2016. The company was incorporated in 2010 and is headquartered in Morrisville, North Carolina. NantHealth, Inc. is a subsidiary of NantWorks, LLC.

Key Stats

• Today's Range: $0.0001 to $0.0001
• 50-Day Range: $0.00 to $0.25
• 52-Week Range: $0.00 to $2.17
• Volume: 898 shs
• Average Volume: 4,183 shs
• Market Capitalization: $3,260.00
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

NHIQ Stock Analysis - Frequently Asked Questions

How have NHIQ shares performed this year?

NantHealth's stock was trading at $0.43 at the beginning of 2024. Since then, NHIQ stock has decreased by 100.0% and is now trading at $0.0001.
View the best growth stocks for 2024 here.

How do I buy shares of NantHealth?

Shares of NHIQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

• Today: 12/21/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Data processing & preparation
• Sub-Industry: Business Services
• Current Symbol: NASDAQ:NHIQ
• CUSIP: N/A
• CIK: 1566469
• Web: www.nanthealth.com
• Phone: (855) 949-6268
• Fax: N/A
• Employees: 365
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $67 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($29.24) per share
• Price / Book: 0.00

Miscellaneous

• Outstanding Shares: 32,600,000
• Free Float: 12,616,000
• Market Cap: $3,260.00
• Optionable: Not Optionable
• Beta: 1.40